chitosan has been researched along with Cancer of Prostate in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 24 (63.16) | 24.3611 |
| 2020's | 11 (28.95) | 2.80 |
| Authors | Studies |
|---|---|
| Katti, K; Katti, KV; Khoobchandani, M; Pasanphan, W; Piroonpan, T; Tangthong, T; Thipe, VC | 1 |
| Bekić, SS; Ćelić, AS; Ignjatović, NL; Kojić, V; Kuzminac, IZ; Savić, MP | 1 |
| Ahmad, T; Anjum, S; Gul, R; Kakar, S; Kousar, K; Naseer, F; Shareef, U | 1 |
| Abdullahi, IN; Abramikas, Z; Agliani, G; Ahangar, N; Ahmed, AR; Aidietis, A; Aiying, W; Alabi, A; Álvarez, K; Anderson, L; André, MR; Araújo-Júnior, JX; Arqué, E; Asakereh, A; Audzijoniene, D; Azer, MK; Bacevicius, J; Badaras, I; Bagaev, A; Bailly, C; Bakky, MAH; Baojun, Y; Baran, E; Barbosa, RFS; Barzon, L; Basit, A; Basler, E; Bassi, ÊJ; Basyte-Bacevice, V; Bielak, K; Bileisiene, N; Birczyński, A; Blom, R; Boesen, L; Boucoiran, I; Bouwknegt, M; Brandão, JA; Bravo, F; Brien, MÈ; Bruijning-Verhagen, PCJL; Butkuviene, M; Cai, DC; Cai, X; Camani, PH; Cao, S; Carey, IM; Chakravarthy, C; Chandler, F; Chang, SW; Chen, C; Chen, H; Chen, J; Chen, S; Chen, T; Chen, W; Chen, X; Chen, Y; Chen, YT; Chen, Z; Chou, WC; Choudhary, S; Chu, W; Chung, H; Cilin, W; Coelho, GL; Collet, C; Cools, C; Cooper, A; Corkhill, CL; Cornelis, JT; Costa, CACB; Currie, A; da S Ferreira, G; da Silva, DJ; Dai, Y; Dal Soglio, D; de Bellegarde de Saint Lary, C; de Bruin, E; de Los Ríos, JD; Deenadayalan, B; Del Río, M; Ding, HT; Dong, GH; Dong, K; Dorożyński, P; Drössler, L; Dvinelis, E; Ebrahimi, M; Fan, W; Fan, Z; Feng, Y; Ferreira, RR; Fortunov, RM; Freitas, JD; Gan, J; Gao, J; García-Depraect, O; Ge, Q; Giglia, G; Giguère, F; Girard, S; Godfrey, J; Gokyar, S; Gonçalves, LR; Gong, S; Gouder, T; Graf, C; Grinter, S; Gröne, A; Gudauskas, M; Guo, T; Guo, Y; Guryanova, OA; Hagan, JL; Hamamoto, K; Hansen, AE; Hasnan, NSN; He, X; He, YL; Hessel, V; Heym, M; Hindle, S; Hogan, CA; Hogema, BM; Hu, J; Hu, P; Huang, M; Huang, S; Huang, X; Huang, Y; Hyatt, NC; Jacobson, C; Jakaite, R; Jasiunas, E; Jeffres, MN; Ji, CF; Jia, K; Jia, Z; Jian, T; Jiang, L; Jiang, W; Jiang, X; Jiang, Y; Jiang, Z; Jiao, Y; Jin, JH; Jing, T; Johnson, L; Ju, L; Jukna, E; Juknevicius, V; Jung, J; Kakkar, F; Kalpana, ML; Kamankesh, M; Kan, E; Kan, N; Karuzas, A; Kasbergen, LMR; Kassim, MB; Ke, Z; Kettles, K; Khan, OA; Khattab, M; Khoee, S; Kiel, E; Kik, M; Kiseliute, M; Kline, JP; Koonce, RC; Koopmans, MPG; Korboulewsky, N; Krause, A; Kulinowski, P; Kundelis, R; La, DD; Lai, HT; Lai, Q; Lange, U; Lasheen, ESR; Latorre-Fernandez, J; Lei, M; Lesperance, J; Li, DC; Li, H; Li, HY; Li, JF; Li, K; Li, L; Li, M; Li, N; Li, P; Li, Q; Li, S; Li, T; Li, WN; Li, X; Li, Y; Li, Z; Liang, C; Liang, H; Liang, M; Liao, H; Liao, Y; Liu, C; Liu, H; Liu, K; Liu, X; Liu, XQ; Liu, Y; Löf, M; Long, Z; Lozano, C; Lu, X; Lühken, R; Luo, H; Lv, T; Lyu, CY; Lyu, T; Løgager, V; Ma, C; Ma, H; Ma, SJ; Machado, RZ; Mafakheri, F; Mahawar, K; Maheshkumar, K; Manga, P; Mao, XR; Marciano, JS; Marinskiene, J; Marozas, V; McGlone, ER; Meester, M; Mella, A; Meng, X; Meng, Z; Meulenbroek, CB; Min, QQ; Mohamed, MA; Molina, D; Monti, G; Mortimer, RJG; Mottram, LM; Mpanya, D; Müller, A; Muñoz, R; Muys, B; Myczko, Ł; Møller, JM; Najib, Y; Navarro, M; Nel, S; Neveln, NK; Nguyen, DD; Nguyen, PHT; Ni, S; Niu, Y; Nomie, K; Nordin, NA; Norvell, MR; Nothdurft, A; Okui, MA; Okui, N; Osei, R; Osorio-Tejada, JL; Ouyang, D; Pach, M; Pan, B; Pan, G; Paredes, R; Párraga-Niño, N; Passos, GFS; Patil, RS; Pedro-Botet, ML; Pelletier, F; Petrylaite, M; Pham, KTT; Pilkiene, A; Ponette, Q; Popov, Y; Porter, M; Postovalova, E; Pretzsch, H; Pring, C; Pu, M; Puigoriol, E; Qi, B; Qi, H; Qi, Y; Qiao, T; Qin, S; Qiu, Y; Qiu, Z; Quero, S; Ramsay, M; Rao, J; Rashwan, MA; Rathod, DK; Rebrov, E; Regueira-Marcos, L; Ren, Y; Reynaga, E; Ricco, MH; Rojas, L; Romero, A; Rosa, DS; Ruiz-Peinado, R; Sang, YQ; Sauer, FG; Schmidt-Chanasit, J; Sepúlveda-García, P; Serra-Pladevall, J; Serras-Pujol, M; Shaki, F; Shao, X; Shen, L; Sheng, Z; Shi, R; Shi, YF; Shou, Q; Shu, L; Shuhua, L; Sikkema, RS; Silva-Júnior, EFD; Simon, C; Small, PK; Smith, SM; Sokas, D; Song, Y; Soudeyns, H; Souza, AG; Souza, BG; Staigyte, J; Stankeviciute, G; Stegeman, A; Stennett, MC; Stollberger, R; Sun, SK; Sun, SP; Sun-Waterhouse, D; Sundgren, NC; Sung, E; Sunseri, N; Suryadevara, SS; Tan, X; Tang, Y; Tao, F; Taparauskaite, N; Ten Bosch, Q; Titeux, H; Tobias, TJ; Tomar, S; Torres, C; Tran, DL; Tran, NT; Trudel, MJ; Tsabedze, N; Tumuluru, S; Um, MJ; Van Bui, C; Van den Brand, JMA; van den Broek, J; van der Jeugd, H; van der Klis, FRM; van der Poel, WHM; van Mastrigt, T; Varlamova, A; Venkataraman, G; Venkateswaran, ST; Venugopal, V; Vilamala, A; Vilela, GG; Visser, LG; Wagdargi, SS; Wan Ishak, WNR; Wan, S; Wang, B; Wang, DJ; Wang, H; Wang, J; Wang, JT; Wang, JY; Wang, L; Wang, LM; Wang, S; Wang, W; Wang, X; Wang, XH; Wang, Y; Wang, Z; Webster, GD; Wei, C; Wei, T; Welbourn, R; Wells, Q; Wiatrowska, B; Wong, M; Wongsomboon, V; Wu, B; Wu, Q; Wu, S; Wu, T; Wu, Y; Wu, Z; Xiang, P; Xiang, Z; Xiao, D; Xiao, L; Xiao, T; Xie, J; Xie, S; Xie, Z; Xu, B; Xu, D; Xu, H; Xue, XS; Yang, J; Yang, Y; Yao, R; Ye, L; Ye, N; Yin, X; You, L; Yu, H; Yu, J; Yun, T; Yuxuan, H; Zaaijer, HL; Zamani, E; Zang, X; Zarazaga, M; Zarembaite, G; Zaroogian, Z; Zarubin, D; Zeeshan, M; Zeng, H; Zeng, S; Zeng, XW; Zha, J; Zha, Y; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, J; Zhang, JZ; Zhang, L; Zhang, M; Zhang, R; Zhang, T; Zhang, X; Zhang, XY; Zhang, Y; Zhang, Z; Zhao, C; Zhao, P; Zhao, R; Zhao, WP; Zhao, Y; Zhao, Z; Zheng, E; Zheng, F; Zheng, H; Zhou, C; Zhou, D; Zhou, Y; Zhu, AX; Zhu, B; Zhu, J; Zhuang, H | 1 |
| Abedi, S; Doosti, A; Jami, MS | 1 |
| Jiao, M; Ju, C; Lin, H; Qu, D; Qu, G; Tian, C; Xue, J; Xue, L; Zhang, C | 1 |
| Chakrabarti, R; Copland, JA; Florczyk, SJ; Wang, Z; Xu, K | 1 |
| Chogan, F; Faraji Dizaji, B; Goleij, P; Hasani Azerbaijan, M; Irani, M; Mirmajidi, T; Sharafian, F; Sheisi, N | 1 |
| Guo, L; Li, J; Liu, X; Meng, D; Shang, M; Shi, D; Sun, X; Zhao, Y; Zhou, X | 1 |
| Eroglu, E | 1 |
| Boni, FI; Campana-Filho, SP; Colnago, LA; Dos Santos, DM; Facchinatto, WM; Gremião, MPD; Leitão, A; Ribeiro, SJL; Silva, DS; Valdes, TA | 1 |
| Bertolo, R; De Cillis, S; Fiori, C; Geuna, S; Manfredi, M; Porpiglia, F | 1 |
| Jang, MK; Kim, YM; Park, SC | 1 |
| Brahman, PK; J S, B; Reddy, KR; Suresh, L | 1 |
| Joon, P; Kumar, P; Narwal, V; Pundir, CS | 1 |
| Afkham, A; Afkham, NM; Aghebati-Maleki, L; Ahmadi, M; Akbarzadeh, P; Dolati, S; Jadidi-Niaragh, F; Sadreddini, S; Siahmansouri, H; Younesi, V; Yousefi, M | 1 |
| Amparore, D; Checcucci, E; De Cillis, S; De Luca, S; Fiori, C; Fregnan, F; Garrou, D; Manfredi, M; Migliaretti, G; Porpiglia, F; Stura, I | 1 |
| Feng, X; Huang, H; Li, M; Wang, L; Xie, X; Xu, X; Yu, J; Zhou, Y | 1 |
| Chen, J; Fu, B; Li, K; Liu, T | 1 |
| Dawaba, AM; Dawaba, HM | 1 |
| Bertolo, R; Fregnan, F; Geuna, S; Haastert-Talini, K; Metzen, J; Muratori, L; Porpiglia, F; Ronchi, G | 1 |
| Andl, T; Chakrabarti, R; Copland, JA; Florczyk, SJ; Ganapathy, K; Wang, Z; Xu, K | 1 |
| Anitha, A; Jayakumar, R; Lakshmanan, VK; Nair, SV; Uthaman, S | 1 |
| Du, M; Luo, J; Peng, Y; Yao, W; Zong, L | 1 |
| Adhami, VM; Bharali, DJ; Cui, H; Khan, N; Mousa, SA; Mukhtar, H; Shabana, SM; Siddiqui, IA | 1 |
| Li, Y; Lin, ZH; Ma, Q; Su, XG; Yang, N | 1 |
| Duan, XL; Han, L; Li, LH; Liang, XJ; Liu, J; Wei, XF; Wei, Y; Zhao, J | 1 |
| Babu Bikkina, DJ; Chinde, S; Kulhari, H; Nikhila, N; Pooja, D; Raghavendra, YM; Sreedhar, B; Tiwari, AK | 1 |
| Aberturas, Mdel R; Huerta, C; Molpeceres, J | 1 |
| Jeong, JH; Kim, K; Kim, MG; Kim, SH; Ku, SH; Kwon, IC; Lee, H; Lee, S; Lee, SJ; Park, JH; Yhee, JY; Yook, S; Yoon, HY | 1 |
| Blessing, AM; Frigo, DE; Gallick, GE; Gaur, S; Ivan, C; Lopez-Berestein, G; Mangala, LS; Parikh, NU; Shi, Y; Song, JH; Sood, AK; Varkaris, A; Wen, Y; Wu, SY | 1 |
| Florczyk, SJ; Kievit, FM; Stephen, ZR; Wang, K; Zhang, M | 1 |
| Huang, T; Landman, J; Wang, PJ; Yang, AQ; Zhou, WL | 1 |
| Abaffy, P; Bäcker, A; Cecilia, A; Dirschka, M; Erhardt, O; Göppert, B; Gruhl, FJ; Schel, N; Sollich, T; Wietbrock, L | 1 |
| Cheong, SJ; Jeong, HJ; Kim, DW; Kim, EM; Lee, CM; Lim, ST; Sohn, MH | 1 |
| Bartels, KE; Chen, WR; Liu, H; Lucroy, MD; Nordquist, RE; Ritchey, JW | 1 |
| Burt, HM; Gleave, ME; Jackson, JK; Springate, CM | 2 |
1 trial(s) available for chitosan and Cancer of Prostate
| Article | Year |
|---|---|
Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study.
Topics: Aged; Biocompatible Materials; Blood Vessels; Chitosan; Erectile Dysfunction; Feasibility Studies; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Tadalafil | 2018 |
37 other study(ies) available for chitosan and Cancer of Prostate
| Article | Year |
|---|---|
Bombesin Peptide Conjugated Water-Soluble Chitosan Gallate-A New Nanopharmaceutical Architecture for the Rapid One-Pot Synthesis of Prostate Tumor Targeted Gold Nanoparticles.
Topics: Bombesin; Cell Line, Tumor; Chitosan; Gold; Humans; Male; Metal Nanoparticles; Peptides; Prostatic Neoplasms; Water | 2021 |
Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
Topics: Breast Neoplasms; Chitosan; Hormones; Humans; Lactones; Male; Nanoparticles; Prostatic Neoplasms; Steroids | 2022 |
Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.
Topics: Caspases; Chitosan; Humans; Hyaluronic Acid; Immunotherapy; Male; Measles virus; Nanoparticles; Oncolytic Viruses; Prostatic Neoplasms; Vaccines | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acrylamides; Actins; Adult; African People; Air Pollutants; Alanine Transaminase; Androgens; Animals; Anti-Bacterial Agents; Antibodies, Bispecific; Antiviral Agents; Arteries; Bioelectric Energy Sources; Bioreactors; Brain; Carbon Dioxide; Carbon Tetrachloride; Cardiomyopathy, Dilated; Cerebral Cortex; Cerebrovascular Circulation; Charcoal; Chemical and Drug Induced Liver Injury; Chikungunya Fever; Chikungunya virus; Chitosan; Chlorocebus aethiops; Claudins; Contrast Media; Cynodon; Cytokines; Desmin; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Ecosystem; Elasticity Imaging Techniques; Escherichia coli; Fatty Acids, Volatile; Female; Fermentation; Filtration; Food; Gadolinium; Galactose; Gastrointestinal Microbiome; Gene Expression; Gene Expression Regulation, Leukemic; Gracilaria; Heart Failure; HeLa Cells; Hematopoietic Stem Cells; Hepatic Stellate Cells; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatocytes; HIV; HIV Infections; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxy Acids; Hydroxyl Radical; Imaging, Three-Dimensional; Immunity; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-33; Interleukin-4; Keratin-18; Kinetics; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Lipidomics; Lipids; Liver; Liver Cirrhosis; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microalgae; Middle Aged; Mutation; Nanoparticles; Nitrogen; Nuclear Proteins; Oxidation-Reduction; Particulate Matter; Phylogeny; Phytoplankton; Placenta; Polysaccharides; Polystyrenes; Polyvinyl Alcohol; Predictive Value of Tests; Pregnancy; Prognosis; Programmed Cell Death 1 Receptor; Prospective Studies; Prostate; Prostatic Neoplasms; Rain; Receptors, Immunologic; Recombinant Proteins; Refuse Disposal; Reproducibility of Results; Restaurants; Retrospective Studies; Reverse Transcriptase Inhibitors; Sand; Seawater; Sheep; Sheep, Domestic; Sodium Hydroxide; Spin Labels; Stomach Neoplasms; Stroke Volume; Sulfates; Tensile Strength; Th1 Cells; Th17 Cells; Th2 Cells; Transcriptome; Tumor Microenvironment; Ultraviolet Rays; Ventricular Function, Left; Vero Cells; Virus Replication; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; Water Supply; Wetlands; Xylitol; Xylose | 2023 |
Evaluation of the preventive and therapeutic effects of a recombinant vector co-expressing prostate-specific stem cell antigen and Clostridium perfringens enterotoxin on prostate cancer in rats.
Topics: Animals; Chitosan; Enterotoxins; Injections, Intramuscular; Male; Methylnitrosourea; Nanoparticles; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Rats, Wistar; Recombinant Proteins; Testosterone | 2020 |
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment.
Topics: Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Gene Expression Regulation, Neoplastic; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Materials Testing; Mice; Micelles; Molecular Targeted Therapy; Paclitaxel; PC-3 Cells; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Xenograft Model Antitumor Assays | 2020 |
3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells.
Topics: Cell Proliferation; Chitosan; Chondroitin Sulfates; Epithelial-Mesenchymal Transition; Humans; Male; Porosity; Prostatic Neoplasms; Tissue Scaffolds; Tumor Microenvironment | 2020 |
Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Male; Metal-Organic Frameworks; Microscopy, Electron, Scanning; Nanofibers; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction; Zeolites | 2020 |
Echogenic, Ultrasound-Sensitive Chitosan Nanodroplets for Spatiotemporally Controlled
Topics: Chitosan; Drug Carriers; Fluorocarbons; Humans; Intercellular Signaling Peptides and Proteins; Male; Nanoparticles; Plasmids; Prostatic Neoplasms; Transfection; Ultrasonic Waves | 2021 |
A Resveratrol-Loaded Poly(2-hydroxyethyl methacrylate)-Chitosan Based Nanotherapeutic: Characterization and
Topics: Chitosan; Drug Carriers; Humans; Male; Methacrylates; Nanoparticles; Prostatic Neoplasms; Resveratrol | 2021 |
N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan: Synthesis, physicochemical and biological properties.
Topics: Animals; BALB 3T3 Cells; Chitosan; Drug Delivery Systems; Epoxy Compounds; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Prostatic Neoplasms; Quaternary Ammonium Compounds; Static Electricity | 2021 |
Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in α
Topics: Animals; Cell Line, Tumor; Chitosan; Dendrimers; Gene Silencing; Gene Transfer Techniques; Humans; Integrins; Male; Mice; Oligopeptides; Polyethyleneimine; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Transfection; Xenograft Model Antitumor Assays | 2017 |
Development of an electrochemical immunosensor based on gold nanoparticles incorporated chitosan biopolymer nanocomposite film for the detection of prostate cancer using PSA as biomarker.
Topics: Biosensing Techniques; Chitosan; Electrochemical Techniques; Equipment Design; Gold; Humans; Male; Metal Nanoparticles; Nanocomposites; Prostate-Specific Antigen; Prostatic Neoplasms | 2018 |
Fabrication of an amperometric sarcosine biosensor based on sarcosine oxidase/chitosan/CuNPs/c-MWCNT/Au electrode for detection of prostate cancer.
Topics: Biosensing Techniques; Chitosan; Copper; Dielectric Spectroscopy; Electrodes; Female; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanotubes, Carbon; Prostatic Neoplasms; Sarcosine; Sarcosine Oxidase | 2018 |
Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.
Topics: Antineoplastic Agents; Cadherins; Camptothecin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chitosan; Claudin-1; Drug Delivery Systems; Humans; Irinotecan; Male; Nanoparticles; Prostatic Neoplasms; RNA, Small Interfering; Snail Family Transcription Factors | 2018 |
Use of chitosan membranes after nerve-sparing radical prostatectomy improves early recovery of sexual potency: results of a comparative study.
Topics: Aged; Biocompatible Materials; Chitosan; Humans; Male; Middle Aged; Organ Sparing Treatments; Penile Erection; Penis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Robotic Surgical Procedures; Treatment Outcome | 2019 |
Development of PSMA-targeted and core-crosslinked glycol chitosan micelles for docetaxel delivery in prostate cancer therapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Docetaxel; Drug Delivery Systems; Humans; Kallikreins; Male; Mice, Inbred BALB C; Micelles; Prostate-Specific Antigen; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2019 |
An electrochemical sarcosine sensor based on biomimetic recognition.
Topics: Biomarkers, Tumor; Biomimetic Materials; Biosensing Techniques; Chitosan; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Limit of Detection; Male; Metal Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Pyrroles; Riboflavin; Sarcosine; Sarcosine Oxidase; Surface Properties | 2019 |
Application of Optimization Technique to Develop Nano-Based Carrier of Nigella Sativa Essential Oil: Characterization and Assessment.
Topics: Anti-Bacterial Agents; Benzoic Acid; Chemistry, Pharmaceutical; Chitosan; Colorectal Neoplasms; Drug Carriers; Drug Delivery Systems; HCT116 Cells; Humans; Inhibitory Concentration 50; Male; Nanoparticles; Nigella sativa; Oils, Volatile; Particle Size; PC-3 Cells; Prostatic Neoplasms; Staphylococcus aureus | 2019 |
New basic insights on the potential of a chitosan-based medical device for improving functional recovery after radical prostatectomy.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cells, Cultured; Chitosan; Disease Models, Animal; Female; Ganglia, Autonomic; Humans; Male; Median Nerve; Nerve Regeneration; Prostatectomy; Prostatic Neoplasms; Prostheses and Implants; Rats; Rats, Wistar; Recovery of Function | 2019 |
3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines.
Topics: Actins; Alginates; Cadherins; Calcification, Physiologic; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Shape; Chitosan; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Proteins; Osteoblasts; Osteocalcin; Phenotype; Porosity; Prostatic Neoplasms; Tissue Scaffolds | 2019 |
Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer.
Topics: Animals; Cell Death; Cell Line, Tumor; Chitosan; Dextrans; Drug Delivery Systems; Flutamide; Humans; Light; Male; Materials Testing; Mice; Nanoparticles; Particle Size; Prostatic Neoplasms; Rhodamine 123; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Whole Blood Coagulation Time | 2013 |
Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
Topics: Administration, Intranasal; Animals; Blotting, Western; Cell Line; Chitosan; Enzyme-Linked Immunosorbent Assay; Immunotherapy; Male; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Nasal Mucosa; Prostatic Neoplasms; Vaccines | 2013 |
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; bcl-2-Associated X Protein; Caspases; Catechin; Cell Proliferation; Chitosan; Enzyme-Linked Immunosorbent Assay; Humans; Immunoblotting; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Nanoparticles; Nanotechnology; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Xenograft Model Antitumor Assays | 2014 |
A novel carboxymethyl chitosan-quantum dot-based intracellular probe for Zn2+ ion sensing in prostate cancer cells.
Topics: Cadmium Compounds; Chitosan; Fluorescence; Humans; Intracellular Space; Ions; Male; Molecular Probes; Prostatic Neoplasms; Quantum Dots; Tellurium; Time Factors; Zinc | 2014 |
A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Topics: bcl-2-Associated X Protein; Cell Proliferation; Cell Survival; Chitosan; Citraconic Anhydrides; Gold; Green Fluorescent Proteins; HeLa Cells; Humans; Male; Metal Nanoparticles; Microscopy, Fluorescence; Plasmids; Polyamines; Polyethyleneimine; Prostatic Neoplasms; Transfection; Tumor Suppressor Protein p53 | 2014 |
Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles.
Topics: Administration, Oral; Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chitosan; Drug Carriers; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Silybin; Silymarin | 2014 |
Nimesulide-loaded nanoparticles for the potential coadjuvant treatment of prostate cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Lactic Acid; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared; Sulfonamides | 2015 |
Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Topics: Animals; Cell Line, Tumor; Chitosan; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Injections, Intravenous; Male; Mice, Nude; Nanoparticles; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; RNAi Therapeutics; Transfection; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Topics: Animals; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Humans; Male; Mice, Nude; MicroRNAs; Nanoparticles; Prostatic Neoplasms; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.
Topics: Alginates; Animals; Chitosan; Female; Genetic Therapy; Glucuronic Acid; Hexuronic Acids; Humans; In Vitro Techniques; Male; Mice; Nanoparticles; Porosity; Prostatic Neoplasms | 2015 |
Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Glutamic Acid; Humans; Inhibitor of Apoptosis Proteins; Male; Nanoparticles; Neoplasm Proteins; Polyethylene Glycols; Prostatic Neoplasms; RNA Interference; Survivin | 2016 |
Silk scaffolds connected with different naturally occurring biomaterials for prostate cancer cell cultivation in 3D.
Topics: Animals; Biocompatible Materials; Bombyx; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Chitosan; Collagen; Elastic Modulus; Fibroins; Gelatin; Humans; Male; Microscopy, Electron, Scanning; Porosity; Prostatic Neoplasms; Recombinant Proteins; Silk; Spheroids, Cellular; Tissue Scaffolds | 2017 |
Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin.
Topics: Animals; Bombesin; Cell Line, Tumor; Chitosan; Female; Fluorescence; Magnetics; Male; Mice; Mice, Nude; Nanoparticles; Neurotransmitter Agents; Prostatic Neoplasms; Receptors, Bombesin | 2010 |
Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
Topics: Adjuvants, Immunologic; Animals; Chitin; Chitosan; Dose-Response Relationship, Immunologic; Female; Immunotherapy; Laser Therapy; Male; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Prostatic Neoplasms; Rats; Rats, Inbred WF | 2002 |
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Clusterin; Delayed-Action Preparations; Docetaxel; Drug Therapy, Combination; Glycoproteins; Humans; Injections, Intralesional; Male; Mice; Mice, Inbred BALB C; Molecular Chaperones; Neoplasm Transplantation; Ointments; Oligonucleotides, Antisense; Paclitaxel; Prostatic Neoplasms; Taxoids; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2005 |
Clusterin antisense complexed with chitosan for controlled intratumoral delivery.
Topics: Blotting, Western; Cell Line, Tumor; Chitosan; Clusterin; Delayed-Action Preparations; Humans; Hydrogen-Ion Concentration; Male; Molecular Weight; Oligonucleotides, Antisense; Particle Size; Prostatic Neoplasms; Solubility; Viscosity | 2008 |